Electron microscopy evidence that cytoplasmic localization of the p16INK4A“nuclear” cyclin-dependent kinase inhibitor (CKI) in tumor cells is specific and not an artifact. A study in non-small cell lung carcinomas-Reference-Cited by-同舟云学术

Electron microscopy evidence that cytoplasmic localization of the p16INK4A“nuclear” cyclin-dependent kinase inhibitor (CKI) in tumor cells is specific and not an artifact. A study in non-small cell lung carcinomas

Published:2004-02 Issue:1 Volume:79 Page:5-10
ISSN:1052-0295
Container-title:Biotechnic & Histochemistry
language:en
Short-container-title:Biotechnic & Histochemistry

Author:

Evangelou K,Bramis* J,Peros I,Zacharatos P,Dasiou-Plakida D,Kalogeropoulos N,Asimacopoulos PJ,Kittas C,Marinos E,Gorgoulis VG

Publisher

Informa UK Limited

Subject

Medical Laboratory Technology,Histology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/10520290310001659466

Reference15 articles.

1. Aberrant cytoplasmic expression of the p16 protein in breast cancer is associated with accelerated tumour proliferation

2. Immunohistochemical localization of c-mos at the light and electron microscope level in non-small cell lung carcinomas

3. Regulation of tumor suppressors by nuclear-cytoplasmic shuttling

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developmental Expression of the Cell Cycle Regulator p16^INK4a in Retinal Glial Cells: A Novel Marker for Immature Ocular Astrocytes?;Journal of Histochemistry & Cytochemistry;2023-06

2. Expression of p16 Tumor Suppressor Protein in Malignant Ovarian Germ Cell Tumors; Immunohistochemical Study;International Journal of Surgical Pathology;2023-05-11

3. Aptima HR-HPV Testing of Cytology Specimens Is an Effective Supplement for p16 Staining to Improve Diagnostic Accuracy for HPV-Related Oropharyngeal Squamous Cell Carcinoma;Acta Cytologica;2022-12-13

4. A motor neuron disease mouse model reveals a non-canonical profile of senescence biomarkers;Disease Models & Mechanisms;2022-08-01

5. Extranodal primary CD20-negative diffuse large B-cell lymphoma with cytoplasmic p16 expression;Biomedical Research and Therapy;2022-06-30